Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real‐World Evidence From a Multicenter Cohort Study [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Mineralocorticoid receptor antagonists (MRAs) reduce mortality and hospitalization in patients with heart failure (HF). Finerenone, a selective nonsteroidal MRA, has recently demonstrated clinical benefits in patients with HF.
Jheng‐Yan Wu +2 more
doaj +2 more sources
Afebrile vancomycin-induced delayed hypersensitivity suggestive of incomplete drug rash with eosinophilia and systemic symptoms syndrome: a case report [PDF]
Journal of Medical Case ReportsBackground Vancomycin-induced delayed hypersensitivity reactions are rare and typically accompanied by systemic symptoms such as fever, eosinophilia, and organ dysfunction, known as drug reaction with eosinophilia and systemic symptoms syndrome. However,
Chien-Hung Chou +3 more
doaj +2 more sources
Nitazoxanide and nonsteroidal anti-inflammatory drugs (NSAIDs): unveiling the connection in immediate hypersensitivity cross-reactions [PDF]
Einstein (São Paulo)Intestinal worm infections, referred to as helminthiases, represent a significant global health challenge, particularly in low- and middle-income countries.
André Luiz Oliveira Feodrippe +4 more
doaj +2 more sources
Nonsteroidal anti‐inflammatory drugs and pharyngitis
Immunity, Inflammation and Disease, 2022 Stuart B Mazzone +3 more
doaj +2 more sources
Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment [PDF]
American Journal of Obstetrics and Gynecology, 2017 Folabomi A. Oladosu +2 more
openalex +2 more sources
Nonsteroid Anti-Inflammatory Agents [PDF]
Annual Review of Pharmacology, 1966 The drugs with which this review will be concerned are those which are useful in the treatment of connective tissue diseases. These disorders are characterized by chronic inflammation, and the drugs used to treat them have the ability to inhibit one or more of the manifestations of inflammation.
M, Weiner, S J, Piliero
+10 more sources
Oral Corticosteroid and Nonsteroidal Immunosuppressant Therapy Use in Patients with Myasthenia Gravis Receiving Ravulizumab, Eculizumab, or Efgartigimod in the USA. [PDF]
Neurol TherSaccà F +4 more
europepmc +3 more sources
Nonopioid analgesics for analgesia in critically ill patients: Friends, enemies, or collaborators [PDF]
Serbian Journal of Anesthesia and Intensive Therapy, 2022 Patients in intensive care units (ICUs) experience pain, which they describe as a significant cause of stress during treatment. It can progress to chronic pain and significantly affect the quality of life.
Orović Stevan +3 more
doaj +1 more source
Postgraduate medicine, 2022 Nonsteroidal mineralocorticoid receptor antagonists (MRAs) are a new class of drugs developed to address the medical need for effective and safer treatment to protect the kidney and the heart in patients with diabetic kidney disease (DKD).
E. Lerma, W. White, G. Bakris
semanticscholar +1 more source
Significance of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in patients with bleeding from upper part of the gastrointestinal tract [PDF]
Vojnosanitetski Pregled, 2007 Background/Aim. Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drugs (NSAIDs) use are considered to be the most important risk factors having influence on the onset of bleeding gastroduodenal lesions.
Golubović Gradimir +4 more
doaj +1 more source